PH3

DRUG2 trials

Sponsors

PhytoHealth Corporation

Conditions

Diabetic NephropathyOsteoporosis

Phase 2

Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women

CompletedNCT00693667

PhytoHealth CorporationOsteoporosis

Start: 2008-02-29End: 2011-07-31Updated: 2021-04-01

Effects of PH3 in Diabetic Nephropathy

CompletedNCT01068041

PhytoHealth CorporationDiabetic Nephropathy

Start: 2010-08-01End: 2015-09-01Updated: 2026-06-03